---
figid: PMC11544154__41598_2024_73736_Fig7_HTML
figtitle: Enhancing DOX efficacy against NSCLC through UDCA-mediated modulation of
  the TGFB/MAPK autophagy pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11544154
filename: 41598_2024_73736_Fig7_HTML.jpg
figlink: /pmc/articles/PMC11544154/figure/F7/
number: F7
caption: This schematic depicts the mechanism by which UDCA suppresses autophagy through
  modulation of the TGFβ/MAPK signaling pathway, thereby sensitizing tumor cells to
  Doxorubicin (DOX) treatment
papertitle: Enhancing DOX efficacy against NSCLC through UDCA-mediated modulation
  of the TGF-β/MAPK autophagy pathways
reftext: Ying Li, et al. Sci Rep. 2024;14(NA).
year: '2024'
doi: 10.1038/s41598-024-73736-7
journal_title: Scientific Reports
journal_nlm_ta: Sci Rep
publisher_name: Nature Publishing Group
keywords: Autophagy | Chemotherapy | Non-small cell lung cancer | Ursodeoxycholic
  acid | Doxorubicin | TGF-β/MAPK pathway | Cancer | Oncology
automl_pathway: 0.9522816
figid_alias: PMC11544154__F7
figtype: Figure
redirect_from: /figures/PMC11544154__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11544154__41598_2024_73736_Fig7_HTML.html
  '@type': Dataset
  description: This schematic depicts the mechanism by which UDCA suppresses autophagy
    through modulation of the TGFβ/MAPK signaling pathway, thereby sensitizing tumor
    cells to Doxorubicin (DOX) treatment
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - EPHB2
  - MAPK1
  - MAPK3
  - CRK
  - MAPK14
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - MAP1LC3B
  - BECN1
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - Nucleus
  - Cancer
---
